The Affordable Inhalers and Nebulizers Act of 2025 is designed to enhance access to affordable prescription inhalers for individuals suffering from respiratory conditions like asthma and chronic obstructive pulmonary disease (COPD). The primary goal of the legislation is to lower the out-of-pocket expenses that patients incur when obtaining these vital medications, particularly benefiting those who are uninsured or have low incomes.